Brisbane, Australia

The Thermo Fisher Scientific site in Brisbane, Australia is a state of the art facility, specializing in clinical and commercial manufacturing, and single use biologics technology. The Brisbane facility won the ISPE “2014 Facility of the Year” for Process Innovation, and is part of our global network of Biologics sites, which also includes Princeton, New Jersey, St. Louis Missouri, and Groningen, Netherlands.

This site specializes in GMP for clinical and commercial manufacturing, including clinical cGMP manufacturing for Phase I, II, & III. Additional capabilities include:

  • In-house analytical capabilities, QC and QA
  • Experience with all mammalian cell lines
  • Fed-batch, perfusion and XD® processes
  • Single-use technologies

cGMP capabilities include both upstream and downstream:

Upstream:

  • 100% single-use bioreactors –HyPerforma& Xcellerex
  • 250–2000 L fed batch
  • 50–500 L XD®/ Perfusion
  • Separate media prep suite
  • Annual output up to 1,000 kg

Downstream:

  • Single-use, multi-use
  • Column and membrane chromatography
  • Depth, dead-end, TFF, micro and nano-filtration
  • Output up to 15 kg per batch
  • Standard DSP/flexible

Being located in Australia, the Brisbane site also offers a favorable R&D tax incentive program.

Learn more about the specific equipment, capabilities, and unique incentives of this site by downloading our Site Fact Sheet.